28/10/201321/10/2023 Helix BioPharma Corp. announces the receipt of subscription agreements admin 0 Comments
15/10/201321/10/2023 Helix BioPharma Corp. Completes Data Review of First Four Cohorts of its Phase I/II Clinical Study for Lung Cancer Drug Candidate L-DOS47 admin 0 Comments
30/09/201321/10/2023 Helix Biopharma Corp. Initiates Enrollment for Fifth Cohort in Polish Phase I/II Clinical Study of its Lung Cancer Drug Candidate L-DOS47 admin 0 Comments
09/09/201321/10/2023 Helix BioPharma Corp. to Conduct Interim Review of its LDOS002 Phase I/II Clinical Study admin 0 Comments
05/09/201321/10/2023 Helix BioPharma Corp. to present at Rodman & Renshaw Annual Global Investment Conference admin 0 Comments
19/07/201321/10/2023 HELIX BIOPHARMA CORP. ANNOUNCES EXTENSION OF 2010 WARRANT EXPIRY DATE admin 0 Comments